llm_output,best_matching_ground_truth,best_evaluation,best_score
Selective serotonin reuptake inhibitors (SSRIs) first-line treatment Major Depressive Disorder during the acute phase,SSRIs Treat Acute phase of depression,"Score: 0.95
The LLM output is highly correct as it accurately conveys the same information as the ground truth statement, but with slightly different wording.",0.95
Monoamine oxidase inhibitors (MAOIs) Specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.90
The LLM output is mostly correct but fails to mention specific atypical features such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection.",0.9
Monoamine oxidase inhibitors (MAOIs) Less commonly used over time due to numerous side effects,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is somewhat related to the ground truth as it mentions side effects, but it does not directly address the slower response to treatment aspect of depression.",0.75
Monoamine oxidase inhibitors (MAOIs) second-line treatment patients who have not responded to several other pharmacotherapies,Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output does not directly match the ground truth statement but provides relevant information about alternative treatments for patients who have not responded to other pharmacotherapies, which is related to the slower response to treatment seen in patients with depression.",0.8
"Monoamine Oxidase Inhibitors (MAOIs) Definition the first class of antidepressants, defined by their mechanism of irreversible inhibition of the enzyme monoamine oxidase",Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.85
The LLM output is mostly correct, providing a definition and explanation of monoamine oxidase inhibitors, but misses the mention of pharmacotherapy in the ground truth statement.",0.85
Electroconvulsive therapy (ECT) Highly effective somatic therapy for depression in some specific situation,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.85
The LLM output is mostly correct, with the addition of ""somatic therapy"" and ""specific situation,"" which are accurate descriptions of ECT for depression.",0.85
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used due to their complex side effects and dietary restrictions,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct in mentioning that monoamine oxidase inhibitors are less commonly used and have complex side effects and dietary restrictions, but it does not directly state that pharmacotherapy entails the use of MAOIs.",0.75
Ketamine Highly effective for treatment-resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct but oversimplifies by stating ketamine is ""highly effective"" for all depression, rather than specifying treatment-resistant depression.",0.75
Monoamine Oxidase Inhibitors (MAOIs) Side effects hepatotoxicity and hypertensive crisis that can lead to lethal intracranial hemorrhage,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output includes additional information about side effects of MAOIs, which is relevant but not directly stated in the ground truth statement.",0.75
Selective serotonin reuptake inhibitors (SSRIs) first-line treatment major depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50
The LLM output is partially correct as it mentions SSRIs as a first-line treatment for major depression, but it fails to accurately represent the concept of Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.5
Monoamine Oxidase Inhibitors (MAOIs) Specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.80

The LLM output captures the main idea of the ground truth statement but simplifies it slightly by not including all specific symptoms that MAOIs can be effective for.",0.8
"Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output matches the ground truth statement exactly, resulting in a perfect score for overall correctness.",1.0
Depression Associated with high rate of suicidal behavior and mortality,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output effectively captures the relationship between depression and suicidal behavior, but the wording is slightly different from the ground truth statement.",0.75
Ketamine Treats resistant unipolar and possibly bipolar depression and acute suicidal ideation,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.90
The LLM output captures the main idea of the ground truth statement but adds information about treating resistant depression and acute suicidal ideation, making it slightly more detailed.",0.9
Ketamine treats treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it mentions a specific medication, but it inaccurately describes it as treating treatment-resistant depression rather than the acute phase of depression.",0.75
Monoamine oxidase inhibitors (MAOIs) specific efficacy in treating depression with atypical features,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.80
The LLM output is mostly correct but lacks specific details mentioned in the ground truth statement.",0.8
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment for patients with major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in stating that SSRIs are a first-line treatment for major depression, but it doesn't accurately reflect the statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.75
Monoamine oxidase inhibitors (MAOIs) less commonly used over time due to side effects,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output partially addresses the topic of MAOIs by mentioning their decreased use over time due to side effects, but it does not directly compare their efficacy to Tricyclic antidepressants as the Ground Truth statement does.",0.75
Bupropion side effects more likely than some SSRIs to lead to minimal weight gain or even weight loss,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.80
The LLM output contains some inaccuracies and slight differences in wording, but overall conveys the correct information.",0.8
Esketamine (S-ketamine) approved for treatment-resistant depression by the FDA,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output is not highly correct as it does not directly relate to the ground truth of problem-solving therapy for preventing and treating mild depressive symptoms in the elderly, but it is somewhat related as it mentions a treatment option for depression.",0.75
"Selective Serotonin Reuptake Inhibitors (SSRIs) Side effects sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache","Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies one of the pharmacotherapy options (SSRIs) for acute-phase depression treatment but does not provide a comprehensive list of treatment approaches as stated in the ground truth.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM correctly identifies SSRIs as first-line treatment for major depression but fails to accurately capture the indication for norepinephrine reuptake inhibitors in patients who do not respond to SSRIs.",0.75
Treatment during the acute phase of a major depressive episode Goal help the patient reach a remission state and eventually return to their baseline level of functioning,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output expands on the concept of treating the acute phase of depression and emphasizes the goal of reaching remission, which aligns with the ground truth, but is slightly less specific.",0.75
Physical Exercise recommended adjunct to other anti-depressive treatment,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.95
The LLM output is highly accurate as it captures the essence of the ground truth statement with minor differences in wording.",0.95
Cognitive-behavioral therapy (CBT) widely used for treating major depressive disorder,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output correctly mentions one of the multiple therapies included in depression-focused psychotherapy, but it does not cover the entire range of treatments.",0.75
Esketamine approved for treatment-resistant depression,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.30
The LLM output is not very correct as it focuses on esketamine approval for treatment-resistant depression rather than deep brain stimulation findings, which had different results.",0.3
"Ketamine side effects neurotoxicity, cognitive dysfunction, and potential for drug abuse","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.75
The LLM output includes some of the common side effects of Ketamine, but it misses several other significant side effects listed in the Ground Truth.",0.75
Tricyclic antidepressants (TCAs) more effective than SSRIs in treating hospitalized patients with severe major depressive disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is partially correct, as it discusses the effectiveness of TCAs in treating severe major depressive disorder, but it does not directly address the eligibility of Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is somewhat relevant as it mentions SSRIs as a first-line treatment for depression, but it does not directly address the eligibility of Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
"Ketamine associated with short antidepressant effect, possible neurotoxicity, and drug dependence",Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is partially correct as it mentions some risks and effects of ketamine, but it does not directly address the treatment of severe forms of depression associated with medications and hospitalization as stated in the Ground Truth.",0.75
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used Major Depression,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct as it includes the correct information about monoamine oxidase inhibitors and their use in major depression, but the wording is slightly different from the ground truth.",0.75
Cognitive Behavioral Therapy (CBT) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.85
The LLM output is mostly correct in identifying Cognitive Behavioral Therapy as a first-line treatment for mild to moderate major depressive disorder, but it could be more specific by mentioning that it is a type of depression-focused psychotherapy.",0.85
Ketamine Treats Treatment-resistant Major Depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
            The LLM output is mostly correct as it mentions Ketamine, which is a type of pharmacotherapy, but it focuses on treatment-resistant major depression instead of just the acute phase of depression.",0.75
Electroconvulsive therapy (ECT) Highly effective All Depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75

The LLM output is mostly correct in summarizing the ground truth statement, but it may oversimplify by implying ECT is effective for all types of depression and not just in some situations.",0.75
Bupropion Side effects Minimal weight gain or even weight loss,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.75
The LLM output is mostly correct but misses the comparison to SSRIs in terms of tolerability.",0.75
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) recommended for chronic depression,"Depression-focused psychotherapy For Depression, psychosocial difficulties, interpersonal problems, and intra-psychic conflicts","Score: 0.75
The LLM output is mostly correct in recommending a specific type of psychotherapy for depression, but it is more specific to chronic depression than the general psychosocial difficulties and interpersonal problems mentioned in the Ground Truth.",0.75
Therapeutic Monitoring of Ketamine Treatment lacks guidelines for depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is somewhat related to the ground truth as it mentions a treatment for depression, but it focuses on ketamine treatment and lacks mention of pharmacotherapy for the acute phase of depression.",0.5
Psychotherapy Treats Mild to moderate Major Depression,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is mostly correct in capturing the essence of the ground truth statement, but it uses slightly different wording.",0.9
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episode in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM Output provides a slightly more specific recommendation by suggesting Interpersonal Therapy as a first-line treatment, but overall captures the essence of the Ground Truth.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is mostly correct by mentioning SSRIs as first-line treatment for major depression, but it incorrectly states that Norepinephrine reuptake inhibitors are eligible for patients who do not respond to SSRIs.",0.75
Cognitive-Behavioral Therapy (CBT) first-line treatment Major Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct but inaccurately states CBT as the first-line treatment for Major Depression instead of Acute phase depression.",0.75
Monoamine Oxidase Inhibitors (MAOIs) less commonly used due to their irreversible inhibition of monoamine oxidase and numerous side effects,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.80
The LLM output provides additional information and context about MAOIs, but could be improved with a mention of their role in pharmacotherapy.",0.8
Physical exercise Associated with Improvement in quality of life for depression patients,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is related to treatment for depression but focuses on physical exercise rather than pharmacotherapy, which is the ground truth.",0.75
Repetitive Transcranial Magnetic Stimulation (rTMS) More effective Depression with mild side effects,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct in stating that rTMS is effective for depression with mild side effects, but it does not mention the other somatic treatments available.",0.75
"Bupropion side effects minimal weight gain or even weight loss, more likely to improve symptoms of fatigue and sleepiness than some SSRIs",SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output gives information about Bupropion's side effects and efficacy in improving symptoms, but does not directly address the statement about SSRIs treating the acute phase of depression.",0.75
Mindfulness-Based Cognitive Therapy (MBCT) Benefits High risk of depressive relapse,Group therapy Reduces Depressive Symptoms,"Score: 0.75
The LLM output is partially correct as it identifies a specific type of therapy (MBCT) that benefits a specific population (high risk of depressive relapse), but it does not directly match the ground truth statement about group therapy reducing depressive symptoms.",0.75
Tricyclic Antidepressants (TCAs) Comparable to SSRIs and MAOIs in treating major depression,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct in stating that Tricyclic Antidepressants are comparable to SSRIs and MAOIs in treating major depression, but it does not directly address the statement about MAOIs having the same efficacy as TCAs.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct but focuses on SSRIs as the first-line treatment for Major Depression rather than Depression-focused psychotherapy for Acute phase depression.",0.75
Electroconvulsive therapy (ECT) Highly effective major unipolar depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as a treatment option for major unipolar depression, but does not mention the other acute-phase treatment options for depression.",0.75
Cognitive-Behavioral Therapy (CBT) first-line treatment mild to moderate major depressive disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is mostly correct in capturing the essence of the ground truth statement, but there are some differences in wording and specificity.",0.9
Ketamine highly effective in intravenous sub-anesthetic dose for resistant unipolar and possibly bipolar depression and acute suicidal ideation,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.90
The LLM output accurately expands on the ground truth statement by specifying the method of administration and emphasizing the effectiveness for resistant unipolar depression and acute suicidal ideation, but may be slightly speculative in regards to bipolar depression.",0.9
Electroconvulsive Therapy (ECT) most effective somatic therapy for resistant forms of depression in specific situations,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is similar in topic but not directly answering the ground truth, as it discusses a specific therapy for resistant forms of depression rather than the general statement about pharmacotherapy for the acute phase of depression.",0.75
"Monoamine Oxidase Inhibitors (MAOIs) less commonly used due to irreversible inhibition of monoamine oxidase, numerous side effects such as hepatotoxicity and hypertensive crisis",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.90
The LLM output is highly correct as it accurately identifies MAOIs as less commonly used, mentions their side effects of hepatotoxicity and hypertensive crisis, while also explaining the reason for their decreased use.",0.9
Mindfulness-Based Cognitive Therapy (MBCT) Treats preventing depressive relapse,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output is not entirely correct as it suggests Mindfulness-Based Cognitive Therapy (MBCT) treats preventing depressive relapse, rather than preventing depression among the elderly and treating patients with mild depressive symptoms as in the ground truth.",0.75
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episodes in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.85
The LLM output accurately captures the essence of the ground truth but lacks the specificity of mentioning ""Depression-focused psychotherapy"" and ""For Mild to moderate MDD.""",0.85
Cognitive Behavioral Therapy (CBT) first-line treatment mild to moderate Major Depressive Disorder,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM Output is mostly correct but could be improved by specifying that the therapy is depression-focused and by using the acronym MDD for Major Depressive Disorder.",0.9
Ketamine Results rapid effect on resistant depression and acute suicidal ideation,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct in summarizing the effects of ketamine on depression, but it fails to mention bipolar depression and focuses more on resistant depression and acute suicidal ideation.",0.75
Physical exercise associated with improvements in quality of life and adjunct to other antidepressant treatment for depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.85
The LLM output captures the main idea of the ground truth but adds additional details and slightly alters the wording.",0.85
Regular physical activity Associated with alleviation of depressive symptoms and prevention of relapse,Group therapy Reduces Depressive Symptoms,"Score: 0.75
The LLM output is somewhat related to the ground truth, as both involve interventions that can reduce depressive symptoms, but the specificity of group therapy in the ground truth statement is missing in the LLM output.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depression,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is partially correct, as it mentions SSRIs as a first-line treatment for Major Depression but does not specifically address the eligibility of Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) second-line treatment patients who do not respond to SSRIs,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct as it mentions alternative treatments for patients who do not respond to SSRIs, but it does not directly address the slower response to treatment associated with depression as mentioned in the ground truth.",0.75
Electroconvulsive therapy (ECT) Highly effective Major unipolar depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.80
The LLM output is mostly correct but lacks specificity in terms of specifying the situation in which electroconvulsive therapy is effective for depression.",0.8
Repetitive Transcranial Magnetic Stimulation (rTMS) Widely used depression research,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output accurately recognizes rTMS as a type of somatic treatment but does not provide information on other treatments or their applications.",0.75
"Psycho-education Benefits improved clinical course, treatment adherence, and psychosocial function in patients with depression",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output addresses the benefits of psycho-education for patients with depression, which is related to depression-focused psychotherapy, but does not directly address it as the second most common treatment for Acute phase depression.",0.75
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episode in adults,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.90
The LLM output is very similar to the ground truth but could be more specific by mentioning ""depression-focused psychotherapy"" as the treatment approach.",0.9
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying SSRIs as a first-line treatment for major depression, but it incorrectly states that SSRIs are the second most common treatment for acute phase depression, which is not accurate.",0.75
Repetitive Transcranial Magnetic Stimulation (RTMS) More effective when combined with antidepressants than placebo conditions with mild side effects and good acceptability,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.85
The LLM output accurately conveys the main idea of the ground truth but includes additional details about combining RTMS with antidepressants, side effects, and acceptability.",0.85
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used over time due to side effects,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output provides additional context and information about the use of MAOIs over time, but doesn't directly address the statement about pharmacotherapy entailing MAOIs.",0.75
"Ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, psychosis, dissociation","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 0.60

The LLM output captures some of the most severe side effects of ketamine but misses several common side effects such as blurred vision, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms.",0.6
Monoamine Oxidase Inhibitors (MAOIs) Less commonly used due to their irreversible inhibition of monoamine oxidase and numerous side effects,Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.80
The LLM output accurately mentions the side effects of MAOIs, but does not specifically mention hepatotoxicity and hypertensive crises, leading to a slightly lower score.",0.8
Vagus Nerve Stimulation (VNS) treats resistant unilateral or bipolar depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output provides an alternative treatment for depression, specifically for resistant unilateral or bipolar depression, but does not directly address the acute phase of depression mentioned in the ground truth.",0.75
"Mirtazapine More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output is mostly correct in stating that Mirtazapine is more effective than several SSRIs, but it incorrectly suggests it is more effective than duloxetine and reboxetine as well, showing a slight lack of accuracy.",0.75
"Escitalopram More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.67
The LLM output is somewhat correct in naming some SSRIs, but it inaccurately ranks escitalopram as the most effective among them.",0.67
"Venlafaxine More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output correctly includes some SSRIs but also incorrectly includes venlafaxine and reboxetine as part of the SSRI class, lowering the overall correctness score.",0.5
"Sertraline More effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output incorrectly lists duloxetine and reboxetine as part of the SSRI class, lowering the overall correctness score.",0.5
Monoamine Oxidase Inhibitors (MAOIs) less commonly used due to irreversible inhibition causing numerous side effects,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output correctly mentions that MAOIs are less commonly used due to numerous side effects, but it does not explicitly state that pharmacotherapy entails MAOIs, leading to a lower overall correctness score.",0.75
Reboxetine Less effective all other tested antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct in mentioning that Reboxetine is less effective compared to other tested antidepressants, but it lacks the specific mention of repetitive Transcranial magnetic stimulation (rTMS) being more effective overall.",0.75
Escitalopram first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is only partially correct as it mentions a specific medication as the first-line treatment for major depression instead of depression-focused psychotherapy, which is the second most common treatment for acute phase depression.",0.5
Sertraline first-line treatment major depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is partially correct as it correctly identifies a first-line treatment for major depression but fails to mention that depression-focused psychotherapy is also a common treatment.",0.5
"Selective Serotonin Reuptake Inhibitors (SSRIs) side effects sexual and digestive issues, irritability, anxiety, insomnia, and headache",Fluvoxamine Side effects Lower acceptability due to reduced efficacy,"Score: 0.75
The LLM output contains some relevant information about SSRIs side effects, but the specific mention of Fluvoxamine and its reduced efficacy is missing, reducing the overall correctness score.",0.75
venlafaxine Comparable to tricyclic antidepressants (TCAs),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is mostly correct as it correctly identifies venlafaxine as comparable to tricyclic antidepressants, but it does not mention monoamine oxidase inhibitors.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment Major Depressive Disorder,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.50

The LLM output correctly identifies SSRIs as a first-line treatment for Major Depressive Disorder, but it does not accurately reflect the ground truth statement regarding Norepinephrine reuptake inhibitors being eligible for patients who do not respond to SSRIs.",0.5
reboxetine Less effective all the other antidepressants tested,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct in comparing the effectiveness of reboxetine with other antidepressants, but it lacks specificity in directly addressing rTMS as being more effective.",0.75
escitalopram and sertraline More effective other second-generation antidepressants,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is not correct as it does not address the comparison between bupropion and SSRIs in improving symptoms of fatigue and sleepiness.",0.5
Repetitive Transcranial Magnetic Stimulation (rTMS) treats depression with improvement in symptoms,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct by mentioning a specific treatment for depression, but it is not completely accurate as it does not directly relate to pharmacotherapy, which is the more common first-line treatment for the acute phase of depression.",0.75
Cognitive Behavioral Therapy (CBT) Overview targets depressed patients' irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.95
The LLM output is almost identical to the ground truth, with just a minor difference in wording.",0.95
"escitalopram and sertraline side effects fewer discontinuations than duloxetine, fluvoxamine, paroxetine, reboxetine, and venlafaxine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly includes two of the SSRI medications (escitalopram and sertraline) but inaccurately includes duloxetine, reboxetine, and venlafaxine which are not SSRIs.",0.75
Electroconvulsive Therapy (ECT) highly effective severe and psychotic depression,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct in identifying Electroconvulsive Therapy (ECT) as an effective somatic treatment, but it is missing other important treatments such as rTMS, tDCS, VNS, DBS, and MST.",0.75
bupropion side effects minimal weight gain or even weight loss,"Bupropion Properties A better tolerability than SSRIs, with minimal weight gain","Score: 0.75
The LLM output is mostly correct, but it could be improved by mentioning the better tolerability of bupropion compared to SSRIs.",0.75
Selective Serotonin Reuptake Inhibitors (SSRIs) first-line treatment major depression,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output is partially correct as it mentions a type of medication used in depression treatment, but it inaccurately identifies SSRIs as first-line treatment instead of Norepinephrine reuptake inhibitors.",0.5
"escitalopram more effective than duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly identifies escitalopram as part of the SSRI group but incorrectly compares its effectiveness with other drugs that are not all SSRIs.",0.75
reboxetine less effective than all other tested antidepressants,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
LLM Output misinterprets the information provided in the ground truth, as it specifically compares reboxetine with other antidepressants, while the ground truth compares different types of treatments for depression.",0.75
"escitalopram more tolerable than duloxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly compares the tolerability of escitalopram with other medications, but it does not mention that escitalopram is one of the SSRIs listed in the ground truth.",0.75
"ketamine side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Ketamine Side effects dizziness, neurotoxicity, cognitive dysfunction, blurred vision, psychosis, dissociation, urological dysfunction, restlessness, headache, nausea, vomiting, and cardiovascular symptoms","Score: 1.00
The LLM output is identical to the Ground Truth, so it receives a perfect score of 1.00.",1.0
"sertraline more tolerable than duloxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.75
The LLM output correctly compares sertraline with other medications, but it lacks information about fluoxetine, citalopram, and escitalopram which are also part of the SSRI group in the ground truth statement.",0.75
Electroconvulsive therapy (ECT) Highly effective major unipolar depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is mostly correct but oversimplifies the effectiveness of electroconvulsive therapy for acute phase depression by not specifying that it is effective in some situations.",0.75
"Escitalopram More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output correctly identifies Escitalopram as part of the SSRI class of medications, but includes other non-SSRI drugs in the list, reducing the overall correctness score.",0.5
"Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies multiple antidepressants as potentially effective, but does not specifically mention repetitive Transcranial Magnetic Stimulation (rTMS) as being more effective, resulting in a slightly lower score.",0.75
Reboxetine Less effective all other 11 antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output is partially related to the ground truth as it mentions antidepressants, but it provides conflicting information about their effectiveness compared to repetitive Transcranial Magnetic Stimulation (rTMS).",0.5
sertraline More commonly used treatment for moderate to severe major depression in adults,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is mostly correct in identifying sertraline as a commonly used treatment for moderate to severe major depression in adults, but it does not directly address the comparison with depression-focused psychotherapy as stated in the ground truth.",0.75
"Venlafaxine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies various antidepressants, but does not explicitly mention repetitive Transcranial Magnetic Stimulation (rTMS) as being more effective overall.",0.75
Interpersonal Therapy (IPT) first-line treatment mild to moderate major depressive episodes in adults and well-established intervention for adolescents with depression,"Depression-focused psychotherapy For Depression, psychosocial difficulties, interpersonal problems, and intra-psychic conflicts","Score: 0.75
The LLM output accurately identifies Interpersonal Therapy (IPT) as a treatment for depression, but it could be improved by mentioning that it also addresses psychosocial difficulties and intra-psychic conflicts.",0.75
"Major Depressive Disorder Treats Escitalopram, Sertraline, Mirtazapine, Venlafaxine",Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The LLM output is incorrect as it provides information on treatments for Major Depressive Disorder, rather than Schema Therapy for patients with personality disorder comorbidity.",0.25
"Mirtazapine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies Mirtazapine as more effective than other antidepressants, but does not specifically mention rTMS as being more effective overall.",0.75
Physical Exercise definition recommended non-pharmacological treatment to alleviate symptoms and prevent relapse of depression,Physical Exercise Finding an adjunct to other Anti-depressive treatments,"Score: 0.90
The LLM output captures the essence of the ground truth statement but lacks some specificity and precision.",0.9
Electroconvulsive therapy (ECT) treats major unipolar depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output accurately summarizes the effectiveness of electroconvulsive therapy in treating major unipolar depression, but it does not fully capture the nuances of the ground truth statement regarding the effectiveness during the acute phase of depression and in some situations.",0.75
Reboxetine less effective all other 11 antidepressants for treating major depression,Monoamine oxidase inhibitors Eligible for Patients who do not respond to other treatments,"Score: 0.75
The LLM output correctly states the comparison of Reboxetine to other antidepressants, but does not mention monoamine oxidase inhibitors specifically.",0.75
Mirtazapine highly effective Major Depressive Disorder,Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output correctly indicates that Mirtazapine is effective for Major Depressive Disorder, but it does not directly compare its effectiveness to SSRIs as stated in the ground truth.",0.75
Sertraline More commonly used treatment of major depression due to better acceptability and fewer discontinuations,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is mostly incorrect as it mentions Sertraline instead of Monoamine oxidase inhibitors and does not address the specific efficacy in treating Atypical features.",0.75
Escitalopram More commonly used treatment of major depression due to better acceptability and fewer discontinuations,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output provides accurate information about a commonly used treatment for major depression, but it does not directly address the slower response to treatment as a side effect of depression.",0.75
"Antidepressants (e.g., sertraline, escitalopram) treats Major Depressive Disorder",Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is partially correct as it mentions a treatment for Major Depressive Disorder, but it does not address the topic of Schema Therapy for treating patients with personality disorder comorbidity.",0.5
Sertraline first-line treatment adults with moderate to severe major depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat related to the ground truth as it also mentions treatment for major depression, but it focuses on sertraline rather than bupropion and does not specify its superiority over SSRIs.",0.75
Escitalopram first-line treatment moderate to severe major depression in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat related to the ground truth, as both refer to treatments for major depressive disorder, but the LLM output focuses on escitalopram specifically rather than comparing it to bupropion.",0.75
"Selective Serotonin Reuptake Inhibitors (SSRIs) side effects sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headache",Transcranial direct current stimulation Results Outperforms the simulator by rate of response and remission,"Score: 0.80

The LLM output is mostly correct in describing the side effects of SSRIs, but does not fully address the comparison with transcranial direct current stimulation.",0.8
Sertraline first-line treatment moderate to severe major depression in adults,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is mostly correct as it mentions sertraline as a first-line treatment for moderate to severe major depression in adults, but it does not directly address the specific efficacy of monoamine oxidase inhibitors for treating atypical features.",0.75
Escitalopram highly effective moderate to severe major depression in adults,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.75
The LLM output is mostly correct in stating the efficacy of escitalopram in treating major depression in adults, but it does not directly address the specific efficacy of monoamine oxidase inhibitors in treating atypical features.",0.75
"Antidepressants (e.g., bupropion, citalopram, escitalopram, sertraline) side effects varies based on the medication",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.50
The LLM output is partially correct as it mentions antidepressants but does not specifically address the side effects of monoamine oxidase inhibitors, which include hepatotoxicity and hypertensive crises.",0.5
"Escitalopram More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly lists various antidepressants, but fails to mention repetitive Transcranial Magnetic Stimulation (rTMS) which was indicated as more effective in the Ground Truth statement.",0.75
"Sertraline More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct in listing various antidepressants, but does not directly mention repetitive transcranial magnetic stimulation (rTMS) and its effectiveness compared to antidepressants.",0.75
"Venlafaxine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output is partially correct as it includes some SSRI medications like fluoxetine, fluvoxamine, and paroxetine, but also includes venlafaxine and duloxetine which are not SSRIs.",0.5
"Mirtazapine More effective Duloxetine, Fluoxetine, Fluvoxamine, Paroxetine, Reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output correctly identifies other SSRIs and SNRIs as potential alternatives to mirtazapine, but incorrectly states that mirtazapine is more effective than them.",0.75
Citalopram first-line treatment major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The LLM output is not correct as it is focusing on a specific medication for major depressive disorder rather than the overall goal of mindfulness-based cognitive therapy in reducing antidepressant treatment and risk of depressive recurrence.",0.5
"Bupropion, Citalopram Well tolerated Duloxetine, Fluvoxamine, Paroxetine, Reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.25
The LLM output is mostly incorrect as it includes medications not classified as SSRIs and missing several of the key medications listed in the ground truth.",0.25
Anxious depression More common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The first statement is not factually accurate, while the second statement is a general observation without clear comparison.",0.5
Citalopram Treats major depressive disorder in adults,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is partially correct as it correctly identifies the treatment of depressive symptoms in adults, but does not mention problem-solving therapy or the specific population of elderly patients.",0.5
Escitalopram first-line treatment adults with moderate to severe major depression,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
The LLM output is mostly correct in identifying a treatment for major depression, but it inaccurately specifies the medication as escitalopram for adults with moderate to severe depression instead of psychotherapy for mild to moderate depression.",0.75
Anxious depression More common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output does not directly relate to the ground truth statement, resulting in a low correctness score.",0.5
Reboxetine not effective as a routine first-line acute treatment for major depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly accurate in highlighting that reboxetine may not be effective for major depression, but does not directly address the slower response to treatment as a side effect of depression.",0.75
Reboxetine less commonly used due to being less efficacious and less tolerable compared to other antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly correct, but it focuses on the comparison of reboxetine to other antidepressants rather than specifically addressing the comparison of repetitive Transcranial Magnetic Stimulation (rTMS) to antidepressants.",0.75
Anxious depression More effective than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output does not accurately represent the information provided in the ground truth, as it completely changes the context and details of the statement.",0.5
Citalopram first-line treatment nonpsychotic major depressive disorder,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The LLM output is relevant to depression treatment but does not accurately reflect the goal of mindfulness-based cognitive therapy as stated in the ground truth.",0.5
Anxious depression Less effective citalopram treatment in achieving remission compared to nonanxious depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.75
The LLM output is partially correct as it mentions depression and treatment, but it introduces a comparison between anxious and nonanxious depression which is not present in the ground truth.",0.75
Anxious depression More common than nonanxious depression,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.50
The LLM output is not directly related to the ground truth statement, resulting in a lower correctness score.",0.5
Anxious depression Associated with significant clinical and sociodemographic differences from those without anxious depression,"Depression-focused psychotherapy Goal To monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events","Score: 0.50
The LLM output is somewhat related to the ground truth in terms of discussing depression, but lacks the specific focus on psychotherapy goals and tools for coping with stress.",0.5
"Antidepressants (e.g., escitalopram, sertraline) more commonly used for their favorable balance between efficacy and acceptability in treating Major Depressive Disorder",Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is generally correct in stating that antidepressants are commonly used for treating Major Depressive Disorder, but it does not specifically address the comparison between MAOIs and Tricyclic antidepressants in terms of efficacy as stated in the ground truth.",0.75
All Depression Treats Cognitive Behavioral Therapy (CBT),"Problem-solving therapy Goal Combines cognitive and interpersonal elements, focusing on negative assessments of situations and problem-solving strategies","Score: 0.60
The LLM output did not accurately reflect the ground truth, as it focused on CBT for depression rather than problem-solving therapy that combines cognitive and interpersonal elements.",0.6
Citalopram first-line treatment major depressive disorder in STAR*D Level 1,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is not highly correct as it is unrelated to the ground truth statement about problem-solving therapy for preventing depression and treating mild depressive symptoms in the elderly.",0.5
Anxious depression Symptom major depressive disorder with high levels of anxiety symptoms,Interpersonal Therapy Goal Identify triggers of depression episodes,"Score: 0.75
The LLM output partially addresses the goal by identifying symptoms related to depression and anxiety, but fails to directly mention triggers of depression episodes as in the ground truth.",0.75
Anxious depression More common than nonanxious depression,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output is partially correct in mentioning that anxious depression is more common than nonanxious depression, but it is not directly related to the ground truth statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.5
Citalopram first-line treatment major depressive disorder in STAR*D study,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The statement provides some relevant information about antidepressant treatment, but does not directly address the goal of reducing or stopping antidepressant treatment through mindfulness-based cognitive therapy.",0.5
Anxious depression Definition major depressive disorder with a baseline HAMD anxiety/somatization factor score of 7 or higher,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output does not directly address the statement about pharmacotherapy treating the acute phase of depression, instead focusing on a definition of anxious depression.",0.5
Anxious depression Associated with lower remission rates compared to nonanxious depression following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct as it discusses the association between anxiety and lower remission rates in depression treatment, which aligns with the concept of slower response to treatment in depression indicated in the ground truth. However, the LLM output does not specifically mention ""side effects"" or the speed of response compared to the ground truth statement.",0.75
Anxious depression More common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is somewhat relevant to the ground truth as it involves the comparison of different outcomes between two options, but the specific details do not align with the original statement.",0.5
"Anxious depression Associated with higher rates of suicidality, unemployment, less education, public insurance, and lower income",Electroconvulsive therapy Goal Lighten the burden of depression,"Score: 0.80
The LLM output contains relevant information about depression, but it does not directly address the goal of electroconvulsive therapy to lighten the burden of depression.",0.8
"Anxious depression Associated with higher rates of severity, illness chronicity, functional impairment, and risk of suicidality",SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output discusses additional factors associated with anxious depression, which is relevant to the overall topic of depression but not directly related to the effectiveness of SSRIs for treating the acute phase.",0.75
Anxious depression Less effective treatment with citalopram than nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output captures the idea that certain types of depression may have different responses to treatment, although it slightly misrepresents the specifics compared to the ground truth statement.",0.8
Anxious depression Associated with poor acute outcome than nonanxious depression following antidepressant treatment,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct in associating anxious depression with a poor outcome in the acute phase of depression, but it does not directly address the effectiveness of pharmacotherapy in treating the acute phase of depression.",0.75
"Anxious depression Associated with Greater severity of depression, more concurrent anxiety disorder, more melancholic/endogenous feature, unemployment, less education, marital status (divorced/widowed), public insurance, lower income",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output provides relevant information about factors associated with anxious depression, but does not directly address the statement about depression-focused psychotherapy being the second most common treatment for acute phase depression.",0.75
Citalopram first-line treatment Major depressive disorder in the STAR*D Level 1 treatment,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.50
The LLM output is not correct as it is discussing the use of Citalopram for Major Depressive Disorder rather than Cognitive-behavioral therapy for first-time treatment as stated in the ground truth.",0.5
Sertraline Recommended as a first choice for the treatment of moderate to severe major depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but is more specific in recommending Sertraline, whereas the ground truth statement is more general in mentioning pharmacotherapy for the acute phase of depression.",0.75
Citalopram Treats major depressive disorder but with differentiated effectiveness in anxious vs nonanxious depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it mentions citalopram treating major depressive disorder in the acute phase, but the mention of effectiveness in anxious vs nonanxious depression slightly deviates from the original statement.",0.75
Anxious depression Less effective citalopram treatment compared to those with nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
LLM output contains relevant information about depression and slower response to treatment, but introduces the concept of citalopram treatment and specifies anxious depression as opposed to nonanxious depression, which are not directly mentioned in the ground truth.",0.75
Anxious depression Benefits Anxious depression taking longer to remit with treatment than nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
LLM output captures the main idea of the ground truth but introduces a slight error by mentioning ""nonanxious depression"" which is not present in the ground truth.",0.75
"Anxious depression Associated with unemployment, low education, public insurance, lower income, severe depression, greater perceived physical impairment, diminished quality of life, later onset of major depression, more concurrent anxiety disorders, more melancholic/endogenous features, more medical comorbidity",Interpersonal Therapy Goal Identify triggers of depression episodes,"Score: 0.75
The LLM output provides relevant factors associated with anxious depression, but does not directly address the specific goal of identifying triggers of depression episodes as stated in the ground truth.",0.75
"Anxious depression Associated with greater side effects frequency, intensity, burden, and more serious adverse events during citalopram treatment",Depression Side effect Suicidal behavior,"Score: 0.75

The LLM output captures the general idea of depression as a side effect and mentions increased side effects during citalopram treatment, but does not directly mention suicidal behavior.",0.75
"Anxious depression Associated with greater side effect frequency, intensity, burden, and more serious adverse events compared to nonanxious depression",Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.80
The LLM output is mostly incorrect as it focuses on comparing anxious and nonanxious depression, instead of discussing Luxtherapy and its benefits for seasonal and non-seasonal depression, sleep deprivation, and drug treatments.",0.8
Anxious depression Associated with greater rate of side effects and serious adverse events compared to nonanxious depression,Transcranial direct current stimulation Results Lower than that of antidepressants and rTMS,"Score: 0.75
The LLM output is mostly correct in highlighting the differences in side effects between anxious and nonanxious depression, but it does not directly compare the effectiveness of different treatments like the ground truth statement.",0.75
"Anxious depression Associated with low socioeconomic status, great severity of depression, late onset of depression, high physical illness burden, and significant clinical and sociodemographic differences",Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.75
The LLM output is partially correct as it provides information related to depression, but it focuses on different aspects such as anxious depression and sociodemographic factors, rather than the specific treatment of depression-focused psychotherapy.",0.75
